Development of a universal Group A Streptococcus Glycoconjugate vaccine (joint with LSHTM)

Project Details

StatusFinished
Effective start/end date1/10/21 → 30/04/24

Funding

  • Wellcome Trust (221589/Z/20/Z): £245,505.00